NOS2 and amyotrophic lateral sclerosis: Analysis of the mRNA expression (**p < 0.01 NC v/s ALS; Fig. 3l) and quantitative analysis of the mean immunofluorescence intensity demonstrated an up-regulation of the iNOS protein in ALS subset compared to the normal controls (***p < 0.001 NC v/s ALS; Fig.3k).